QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 inotiv-says-timeline-for-completion-of-restoration-efforts-related-to-cybersecurity-incident-is-not-yet-known-not-yet-determined-if-2025-cybersecurity-incident-is-likely-to-have-material-impact

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000720154/000162828025042837/notv-20250821.htm

 inotiv-enters-settlement-agreement-for-securities-class-action-2025-cybersecurity-incident-is-expected-to-continue-to-cause-disruptions-to-certain-business-operations-of-co-to-pay-875m-cash-settlement

https://www.sec.gov/ix?doc=/Archives/edgar/data/0000720154/000162828025042837/notv-20250821.htm

 inotiv-files-for-mixed-shelf-offering-of-up-to-3500m

-SEC Filing

 inotiv-q3-eps-051-beats-052-estimate-sales-130683m-beat-127052m-estimate

Inotiv (NASDAQ:NOTV) reported quarterly losses of $(0.51) per share which beat the analyst consensus estimate of $(0.52) by 0.9...

 sec-division-of-enforcement-ends-probe-recommends-no-action-against-inotiv

As previously disclosed, on May 23, 2023, Inotiv, Inc. (the "Company") received a voluntary request from the U.S. Secur...

 lake-street-maintains-buy-on-inotiv-lowers-price-target-to-5

Lake Street analyst Frank Takkinen maintains Inotiv (NASDAQ:NOTV) with a Buy and lowers the price target from $6 to $5.

 nvidia-backed-recursion-ginkgo-bioworks-rally-following-fdas-decision-to-end-animal-testing

FDA announces plan to end mandatory animal testing of new drugs, replacing it with more effective and human relevant methods.

 inotiv-q1-eps-102-beats-103-estimate-sales-11988m-miss-12183m-estimate

Inotiv (NASDAQ:NOTV) reported quarterly losses of $(1.02) per share which beat the analyst consensus estimate of $(1.03) by 0.9...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION